Case and research letter
Primary Anetoderma Associated With Primary Sjögren Syndrome and Anticardiolipin Antibodies
Anetodermia primaria asociada a síndrome de Sjögren primario y anticuerpos anticardiolipina
Leído
11232
Vecesse ha leído el artículo
3587
Total PDF
7645
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 145 | 5 | 150 |
| 2025 5 | 309 | 49 | 358 |
| 2025 4 | 250 | 38 | 288 |
| 2025 3 | 216 | 31 | 247 |
| 2025 2 | 245 | 36 | 281 |
| 2025 1 | 159 | 36 | 195 |
| 2024 12 | 143 | 43 | 186 |
| 2024 11 | 136 | 75 | 211 |
| 2024 10 | 108 | 67 | 175 |
| 2024 9 | 126 | 38 | 164 |
| 2024 8 | 163 | 113 | 276 |
| 2024 7 | 137 | 62 | 199 |
| 2024 6 | 150 | 79 | 229 |
| 2024 5 | 153 | 54 | 207 |
| 2024 4 | 121 | 30 | 151 |
| 2024 3 | 101 | 43 | 144 |
| 2024 2 | 96 | 35 | 131 |
| 2024 1 | 86 | 69 | 155 |
| 2023 12 | 80 | 31 | 111 |
| 2023 11 | 81 | 55 | 136 |
| 2023 10 | 105 | 186 | 291 |
| 2023 9 | 107 | 181 | 288 |
| 2023 8 | 80 | 214 | 294 |
| 2023 7 | 108 | 207 | 315 |
| 2023 6 | 77 | 55 | 132 |
| 2023 5 | 111 | 47 | 158 |
| 2023 4 | 90 | 40 | 130 |
| 2023 3 | 74 | 32 | 106 |
| 2023 2 | 60 | 34 | 94 |
| 2022 1 | 57 | 47 | 104 |
| 2022 12 | 59 | 48 | 107 |
| 2022 11 | 36 | 29 | 65 |
| 2022 10 | 34 | 23 | 57 |
| 2022 9 | 49 | 35 | 84 |
| 2022 8 | 28 | 33 | 61 |
| 2022 7 | 34 | 28 | 62 |
| 2022 6 | 44 | 30 | 74 |
| 2022 5 | 55 | 31 | 86 |
| 2022 4 | 53 | 30 | 83 |
| 2022 3 | 63 | 51 | 114 |
| 2022 2 | 61 | 27 | 88 |
| 2021 1 | 46 | 41 | 87 |
| 2021 12 | 49 | 35 | 84 |
| 2021 11 | 47 | 50 | 97 |
| 2021 10 | 63 | 43 | 106 |
| 2021 9 | 48 | 43 | 91 |
| 2021 8 | 54 | 32 | 86 |
| 2021 7 | 52 | 32 | 84 |
| 2021 6 | 54 | 37 | 91 |
| 2021 5 | 39 | 36 | 75 |
| 2021 4 | 99 | 36 | 135 |
| 2021 3 | 80 | 26 | 106 |
| 2021 2 | 55 | 32 | 87 |
| 2020 1 | 39 | 21 | 60 |
| 2020 12 | 48 | 23 | 71 |
| 2020 11 | 27 | 15 | 42 |
| 2020 10 | 26 | 8 | 34 |
| 2020 9 | 28 | 17 | 45 |
| 2020 8 | 23 | 24 | 47 |
| 2020 7 | 24 | 8 | 32 |
| 2020 6 | 35 | 33 | 68 |
| 2020 5 | 23 | 22 | 45 |
| 2020 4 | 40 | 17 | 57 |
| 2020 3 | 22 | 22 | 44 |
| 2020 2 | 9 | 4 | 13 |
| 2020 1 | 4 | 3 | 7 |
| 2019 12 | 8 | 6 | 14 |
| 2019 11 | 4 | 2 | 6 |
| 2019 10 | 0 | 5 | 5 |
| 2019 9 | 14 | 4 | 18 |
| 2019 8 | 4 | 11 | 15 |
| 2019 7 | 4 | 7 | 11 |
| 2019 6 | 4 | 8 | 12 |
| 2019 5 | 6 | 16 | 22 |
| 2019 4 | 3 | 14 | 17 |
| 2019 3 | 0 | 9 | 9 |
| 2019 2 | 6 | 0 | 6 |
| 2019 1 | 1 | 0 | 1 |
| 2018 11 | 4 | 0 | 4 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 3 | 0 | 3 |
| 2018 8 | 0 | 1 | 1 |
| 2018 6 | 0 | 2 | 2 |
| 2018 5 | 0 | 7 | 7 |
| 2018 4 | 0 | 2 | 2 |
| 2018 3 | 2 | 5 | 7 |
| 2018 2 | 55 | 4 | 59 |
| 2018 1 | 59 | 6 | 65 |
| 2017 12 | 55 | 14 | 69 |
| 2017 11 | 47 | 6 | 53 |
| 2017 10 | 44 | 7 | 51 |
| 2017 9 | 43 | 13 | 56 |
| 2017 8 | 53 | 15 | 68 |
| 2017 7 | 29 | 11 | 40 |
| 2017 6 | 55 | 18 | 73 |
| 2017 5 | 79 | 17 | 96 |
| 2017 4 | 43 | 8 | 51 |
| 2017 3 | 64 | 25 | 89 |
| 2017 2 | 100 | 11 | 111 |
| 2016 1 | 28 | 17 | 45 |
| 2016 12 | 54 | 12 | 66 |
| 2016 11 | 83 | 14 | 97 |
| 2016 10 | 86 | 17 | 103 |
| 2016 9 | 162 | 19 | 181 |
| 2016 8 | 171 | 15 | 186 |
| 2016 7 | 69 | 10 | 79 |
| 2016 6 | 4 | 13 | 17 |
| 2016 5 | 15 | 11 | 26 |
| 2016 4 | 8 | 1 | 9 |
| 2016 3 | 3 | 1 | 4 |
| 2016 2 | 8 | 2 | 10 |
| 2015 1 | 5 | 2 | 7 |
| 2015 12 | 4 | 1 | 5 |
| 2015 11 | 5 | 7 | 12 |
| 2015 10 | 12 | 10 | 22 |
| 2015 9 | 2 | 1 | 3 |
| 2015 8 | 5 | 1 | 6 |
| 2015 7 | 58 | 8 | 66 |
| 2015 6 | 37 | 7 | 44 |
| 2015 5 | 59 | 7 | 66 |
| 2015 4 | 50 | 10 | 60 |
| 2015 3 | 49 | 6 | 55 |
| 2015 2 | 68 | 7 | 75 |
| 2015 1 | 33 | 2 | 35 |
| 2014 12 | 42 | 7 | 49 |
| 2014 11 | 30 | 10 | 40 |
| 2014 10 | 54 | 8 | 62 |
| 2014 9 | 28 | 5 | 33 |
| 2014 8 | 27 | 4 | 31 |
| 2014 7 | 34 | 8 | 42 |
| 2014 6 | 37 | 5 | 42 |
| 2014 5 | 25 | 9 | 34 |
| 2014 4 | 35 | 8 | 43 |
| 2014 3 | 24 | 8 | 32 |
| 2014 2 | 14 | 3 | 17 |
| 2014 1 | 1 | 0 | 1 |
Mostrar todo
